BioNTech CEO Reveals "Biggest Challenge" After Covid Vaccine Gets US Nod

The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up...

https://ift.tt/eA8V8J